PINKvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with PINK, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PINK performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/16/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PINK ETF 2 | +5.72%– | +9.91%– | +6.64%– | +30.06%– | +48.34%– | n/a– |
| Flows | PINK ETF 2 | +$52M– | +$113M– | +$15M– | +$192M– | +$246M– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PINK ETF 2 | +16.48%– | +18.08%– | +16.93%– | n/a– |
| Max drawdown | PINK ETF 2 | -5.27%– | -16.68%– | -18.81%– | n/a– |
| Max drawdown duration | PINK ETF 2 | 22d– | 154d– | 390d– | n/a– |
Trading data
PINK | ETF 2 | |
Last sale 7/17/2026 at 1:30 PM | $38.89 | – |
| Previous close 07/16/2026 | $38.94 | – |
| Consolidated volume 07/16/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 7/17/2026 at 1:30 PM
Live
Closed
PINK | ETF 2 | |
|---|---|---|
| Last price | $38.89 | – |
| 1D performance | -0.13% | – |
| AuM | $377.02 M | – |
| E/R | 0.51% | – |
Characteristics
PINK | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | Simplify | – |
| Benchmark | - | – |
| N° of holdings | 52 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | October 7, 2021 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
PINK
USA
85.43%
Other
14.57%
ETF 2
Sectors
PINK
Healthcare
82.51%
Non-Energy Materi.
10.31%
Other
7.18%
ETF 2
Advertisement
Diversification
PINK
Total weight of top 15 holdings out of 15
72.47%
ETF 2
–
Top 15 holdings
Data as of May 31, 2026
PINK
Purecycle Technologies, Inc.
10.31%
United Therapeutics Corp.
7.72%
Novo Nordisk A/S
6.56%
Eli Lilly & Co.
5.54%
Johnson & Johnson
5.21%
Jazz Pharmaceuticals Plc
4.79%
UnitedHealth Group, Inc.
4.60%
Align Technology, Inc.
4.15%
AbbVie, Inc.
4.04%
Warby Parker, Inc.
3.94%
Biohaven Ltd.
3.53%
Gilead Sciences, Inc.
3.20%
Thermo Fisher Scientific, Inc.
3.04%
10X Genomics, Inc.
2.95%
Benitec Biopharma, Inc.
2.90%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
